-
"One of the nation's premier plaintiffs' firms."
American Lawyer
-
"Representing the best qualities of the plaintiffs' bar."
The National Law Journal
-
"Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."
The Daily Journal
-
-
-
Super Lawyers Nationwide
-
Media Center
Halting Bone-Building Osteoporosis Drug Use Significantly Reduces Likelihood Of Additional Fractures
February 8, 2012
In February 8, 2012 press release, the American Academy of Orthopaedic Surgeons stated that, "There is growing evidence that supports an association between atypical fractures of the femur... and the use of bisphosphonates, drugs proven to enhance bone density and reduce fracture incidence caused by osteoporosis." It is thought that these types of drugs may undermine the body's bone remodeling abilities leaving patients more vulnerable to future breaks.
The academy noted that a recent study found that, "The incidence of a subsequent atypical femur fracture occurring in the other thigh was 53.9 percent in patients who continued bisphosphonates for three or more years after their first fracture, compared to 19.3 percent in patients who discontinued bisphosphonate use."
To learn more about bisphsphonate drugs and risks from long-term use of these drugs pose, please visit our osteoporosis drug side effects page.
Current Cases
Personal Injury Brochure
-
Read a copy of our Personal Injury Practice Area Brochure.